References
- Yeh HC, Liu CC, Lee YC, et al. Associations of the lower urinary tract symptoms with the lifestyle, prostate volume, and metabolic syndrome in the elderly males. Aging Male 2012;15:166–72
- Aktas BK, Gokkaya CS, Bulut S, et al. Impact of metabolic syndrome on erectile dysfunction and lower urinary tract symptoms in benign prostatic hyperplasia patients. Aging Male 2011;14:48–52
- Demir O, Akgul K, Akar Z, et al. Association between severity of lower urinary tract symptoms, erectile dysfunction and metabolic syndrome. Aging Male 2009;12:29–34
- Russo GI, Cimino S, Fragala E, et al. Insulin resistance is an independent predictor of severe lower urinary tract symptoms and of erectile dysfunction: results from a cross-sectional study. J Sex Med 2014;11:2074–82
- Gacci M, Eardley I, Giuliano F, et al. Critical analysis of the relationship between sexual dysfunctions and lower urinary tract symptoms due to benign prostatic hyperplasia. Eur Urol 2011;60:809–25
- He Q, Wang H, Yue Z, et al. Waist circumference and risk of lower urinary tract symptoms: a meta-analysis. Aging Male 2014;17:223–9
- Ferreira FT, Daltoe L, Succi G, et al. Relation between glycemic levels and low tract urinary symptoms in elderly. Aging Male 2015;18:34–7
- Gacci M, Vignozzi L, Sebastianelli A, et al. Metabolic syndrome and lower urinary tract symptoms: the role of inflammation. Prostate Cancer Prostatic Dis 2013;16:101–6
- Vignozzi L, Gacci M, Cellai I, et al. PDE5 inhibitors blunt inflammation in human BPH: a potential mechanism of action for PDE5 inhibitors in LUTS. Prostate 2013;73:1391–402
- Vanella L, Russo GI, Cimino S, et al. Correlation between lipid profile and heme oxygenase system in patients with benign prostatic hyperplasia. Urology 2014;83:1444 e7–13
- Fusco F, D’Anzeo G, Sessa A, et al. BPH/LUTS and ED: common pharmacological pathways for a common treatment. J Sex Med 2013;10:2382–93
- Bouwman, II, Blanker MH, Schouten BW, et al. Are lower urinary tract symptoms associated with cardiovascular disease in the Dutch general population? Results from the Krimpen study. World J Urol 2014 . [Epub ahead of print]. doi: 10.1007/s00345-014-1398-y
- Russo GI, Castelli T, Privitera S, et al. Increase of Framingham risk score is associated with severity of Lower urinary tract symptoms. BJU Int 2015 . [Epub ahead of print]. doi: 10.1111/bju.13053
- Vignozzi L, Filippi S, Comeglio P, et al. Nonalcoholic steatohepatitis as a novel player in metabolic syndrome-induced erectile dysfunction: an experimental study in the rabbit. Mol Cell Endocrinol 2014;384:143–54
- Russo GI, Cimino S, Fragala E, et al. Relationship between non-alcoholic fatty liver disease and benign prostatic hyperplasia/lower urinary tract symptoms: new insights from an Italian cross-sectional study. World J Urol 2014 . [Epub ahead of print]. doi: 10.1007/s00345-014-1392-4
- Favilla V, Cimino S, Salamone E, et al. Risk factors of sexual dysfunction after transurethral resection of the prostate (TURP): a 12 months follow-up. J Endocrinol Investig 2013;36:1094–8